Meinian Onehealth Hits Day High with 4.22% Surge Amid Market Decline

Meinian Onehealth Healthcare Holdings Co., Ltd. has experienced a notable increase of 4.22% on February 25, 2026, reaching an intraday high of CNY 7.06. This performance stands in contrast to the China Shanghai Composite, which declined by 1.26% on the same day. Despite the positive movement today, the stock has shown mixed performance over different time frames. Over the past week, it has decreased by 0.57%, and over the last month, it has seen a decline of 10.48%. However, on a year-to-date basis, Meinian Onehealth has performed well, with a gain of 31.06%. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 26,659 million. Key financial metrics indicate a Price-to-Earnings (P/E) ratio of 51.00 and a Return on Equity (ROE) of 4.95%. The stock also features a dividend yield of 0.20%. While the company has faced challenges, including a significant drop in net profit, its recent performance highlights a moment of recovery in the market.